Admission Date:  [**2152-10-13**]              Discharge Date:   [**2152-10-22**]  Date of Birth:  [**2110-1-16**]             Sex:   M  Service: PLASTIC  Allergies: Amphotericin B / Ambisome / Campath  Attending:[**First Name3 (LF) 5667**] Chief Complaint: Right facial wound and cervicofacial sarcoma.
Right anterolateral free flap to right face using the    right facial artery and common facial vein.
Split thickness skin graft 14 x 20 cm at 0.014 inch.
History of Present Illness: The patient is a 42-year-old male who is a patient of Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 1837**] with a history of total body irradiation as well as graft versus host disease following bone marrow transplant several years ago.
The lesion was fully excised and margins were sent off and a bolster dressing was placed.
He presents to the office for changes of the dressing and removal of the bolster and preoperative planning.
GVHD--symptoms have included severe skin findings, thrombocytopenia requiring transfusions, bronchiolitis obliterans and mouth sores.
treatment options are limited, since the patient has also had HUS to calcineurin inhibitors such as cyclosporine, FK 506, no response to rapamycin, has had multiple trials of Rituxan as well as trial of endostatin all without signficant improvement.
He unfortunately has had multiple prior therapies including Rituxan, pentostatin, Campath, steroids, and CellCept.
He has had a significant issue as in the past with cyclosporin and FK-506.
portacath in place #.
Pertinent Results: [**2152-10-13**] 01:47PM BLOOD WBC-7.9 RBC-2.48* Hgb-8.7* Hct-25.9* MCV-104* MCH-35.2* MCHC-33.7 RDW-16.0* Plt Ct-378 [**2152-10-18**] 03:12AM BLOOD WBC-7.9 RBC-2.33* Hgb-7.9* Hct-23.6* MCV-101* MCH-33.8* MCHC-33.4 RDW-17.2* Plt Ct-250 [**2152-10-13**] 01:47PM BLOOD Plt Ct-378 [**2152-10-13**] 09:40PM BLOOD PT-11.3 PTT-23.3 INR(PT)-1.0 [**2152-10-17**] 01:46AM BLOOD PT-11.2 PTT-25.4 INR(PT)-0.9 [**2152-10-18**] 03:12AM BLOOD Plt Ct-250 [**2152-10-13**] 09:40PM BLOOD Glucose-114* UreaN-15 Creat-1.0 Na-139 K-4.9 Cl-107 HCO3-27 AnGap-10 [**2152-10-18**] 03:12AM BLOOD Glucose-94 UreaN-20 Creat-1.0 Na-141 K-4.4 Cl-108 HCO3-24 AnGap-13 [**2152-10-13**] 09:40PM BLOOD Calcium-9.0 Phos-3.0 Mg-2.1 [**2152-10-18**] 03:12AM BLOOD Calcium-8.8 Phos-3.8 Mg-2.6 [**2152-10-13**] 06:50PM BLOOD Type-ART Temp-36.6 Rates-/8  Tidal V-600 FiO2-40 pO2-176* pCO2-43 pH-7.44 calTCO2-30 Base XS-5 Intubat-INTUBATED Vent-CONTROLLED [**2152-10-14**] 03:30AM BLOOD Type-ART Tidal V-550 pO2-186* pCO2-45 pH-7.40 calTCO2-29 Base XS-2 -ASSIST/CON Intubat-INTUBATED [**2152-10-16**] 06:05AM BLOOD Type-ART pO2-178* pCO2-40 pH-7.43 calTCO2-27 Base XS-2 [**2152-10-17**] 09:25AM BLOOD Type-ART pO2-86 pCO2-36 pH-7.50* calTCO2-29 Base XS-4 [**2152-10-13**] 06:50PM BLOOD Glucose-81 Na-137 K-4.3 [**2152-10-13**] 06:50PM BLOOD Hgb-10.1* calcHCT-30 [**2152-10-13**] 06:50PM BLOOD freeCa-1.16 [**2152-10-17**] 01:54AM BLOOD freeCa-1.18  Brief Hospital Course: Pt.
admitted and operation proceded with.
remained sedated and ventilated due to tenuous nature of flap and prominent facial edema.
transferred to ICU for further care/ventilation/q2hr flap checks without incident.
An NG tube was placed and tube feeds were slowly advanced during this time, begining on [**10-15**].
Nutrition was consulted and provided excellent assisstance with tube feeding recs.
Tube feeds were slowly increased and eventually moved to bolus feeds.
Facial/flap edema slowly decreased and one drain was removed.
PT saw the patient and assissted with post-discharge care.
Medications on Admission: acyclovir Prednisone 5 metoprolol Folic Acid  Discharge Medications: 1.
Acetaminophen 325 mg Tablet Sig: One (1) Tablet PO Q6H (every 6 hours) as needed for fever.
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Polyvinyl Alcohol-Povidone 1.4-0.6 % Dropperette Sig: [**2-8**] Drops Ophthalmic PRN (as needed).
Prednisone 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Bacitracin Zinc 500 unit/g Ointment Sig: One (1) Appl Topical [**Hospital1 **] (2 times a day).
Famotidine 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Metoprolol Succinate 25 mg Tablet Sustained Release 24 hr Sig: One (1) Tablet Sustained Release 24 hr PO DAILY (Daily).
Oxycodone-Acetaminophen 5-325 mg/5 mL Solution Sig: 5-10 MLs PO Q4H (every 4 hours) as needed for pain.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO twice a day.
Amoxicillin-Pot Clavulanate 875-125 mg Tablet Sig: One (1) Tablet PO twice a day for 10 days.
Acyclovir 200 mg Capsule Sig: One (1) Capsule PO Q8H (every 8 hours) for 10 days.
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Certain pain medications may have side effects such as drowsiness.
Do not operate heavy machinery while on these medications.
Certain pain medications such as percocet or codeine can cause constipation.
Please keep track of JP drain output for your follow-up visit.
Please continue to take antibiotics until your drains are out.
If you run out of antibiotics before your drains are removed, please call us immediately to get a refill.
Please resume previous medications as prior to your surgery.
Please take pain medications and stool softener as prescribed.
